Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen

Stock Track

03-06

Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.

In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.

Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1132052591"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132052591\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1132052591?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-06 04:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132052591","market":"us","top_or_hot":-1,"title":"Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen","media":"Stock Track","content":"<p>Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.</p>\n\n<p>In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.</p>\n\n<p>Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vera Therapeutics Soars 5.21% on Buy Rating and Price Target Increase from TD Cowen\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-03-06 04:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.</p>\n\n<p>In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.</p>\n\n<p>Vera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VERA","symbol_name":"Vera Therapeutics, Inc.","start_time":0,"source_url":"","article_id":"1132052591","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132052591","pubTimestamp":1741208059,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vera Therapeutics, Inc.  stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.In a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.Vera Therapeutics is a biopharmaceutic","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VERA":"Vera Therapeutics, Inc."},"translate_title":"TD Cowen给予Vera Therapeutics买入评级并上调目标价，股价飙升5.21%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERA":1},"content_text":"Vera Therapeutics, Inc. (VERA) stock soared 5.21% in intraday trading on Wednesday, following a Buy rating and price target increase from TD Cowen analyst Ritu Baral.\nIn a research report released today, Baral maintained a Buy rating on VERA and raised the price target, citing the company's promising drug pipeline and potential for significant growth. The analyst's positive outlook on VERA's prospects has boosted investor confidence, driving the stock price higher.\nVera Therapeutics is a biopharmaceutical company focused on developing innovative therapies for various diseases. The company's drug candidates have shown promising results in clinical trials, leading analysts to be optimistic about their future success.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}